Document is current
Any future updates will be listed below
-
Authors
Dong, Weifan
Fekete, Adam
Chen, Xiaodi
Liu, Hongwei
Beilhartz, Greg L. http://orcid.org/0000-0002-8142-9444
Chen, Xin http://orcid.org/0000-0001-7620-5975
Bahrampour, Shahrzad http://orcid.org/0000-0002-2671-3645
Xiong, Yi
Yang, Qi http://orcid.org/0000-0001-8164-2141
Zhao, Hongyu
Kong, Tian
Morioka, Malia S.
Jung, Geena
Kim, Ji-Eun
Schramek, Daniel http://orcid.org/0000-0001-9977-2104
Dirks, Peter B. http://orcid.org/0000-0001-5718-6465
Song, Yuanquan http://orcid.org/0000-0001-7699-2059
Kim, Tae-Hee http://orcid.org/0000-0002-4872-1742
He, Ye
Wanggou, Siyi
Li, Xuejun
Melnyk, Roman A.
Wang, Lu-Yang
Huang, Xi http://orcid.org/0000-0002-7177-7525
- License Information
-
More Information
Article History
Received: 19 July 2022
Accepted: 2 August 2023
First Online: 11 September 2023
Competing interests
: W.D. and X.H. have filed a PCT patent for the composition of matter and use of designer peptides to treat cancer. The remaining authors declare no competing interests.
